Form 4: GlycoMimetics Director Acquires Stock Options
SEC Form 4 Filing
Director Scott Thomas Jackson acquires stock options in GlycoMimetics, Inc.
Summary
- On May 1, 2024, Scott Thomas Jackson, a director of GlycoMimetics, Inc. (GLYC), acquired stock options.
- The transaction involved the acquisition of options to purchase 40,000 shares of common stock at an exercise price of $1.62 per share.
- The options vest on May 1, 2025, contingent upon the director's continued service.
- Following the transaction, Jackson directly owns options for 40,000 shares.
Sentiment
Score: 5
Explanation: Neutral sentiment as it's a standard disclosure of insider activity. The acquisition of options could be interpreted as a positive signal, but it's not definitive.
Positives
- The acquisition of stock options by a director could be seen as a positive sign, indicating confidence in the company's future performance.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency regarding the transactions of company insiders. This allows investors to monitor the actions of those with privileged information.
Stakeholder Impact
- The acquisition of stock options by a director may influence investor sentiment regarding the company's prospects.
Key Dates
| Date | Description |
|---|---|
| 05/01/2024 | Date of stock option acquisition |
| 05/01/2025 | Vesting date for the stock options |
| 04/30/2034 | Expiration date for the stock options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.